A detailed history of Asset Management One Co., Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 720,740 shares of ABT stock, worth $82.7 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
720,740
Previous 705,203 2.2%
Holding current value
$82.7 Million
Previous $73.3 Million 12.14%
% of portfolio
0.3%
Previous 0.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $1.55 Million - $1.84 Million
15,537 Added 2.2%
720,740 $82.2 Million
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $2.28 Million - $2.54 Million
-22,624 Reduced 3.11%
705,203 $73.3 Million
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $2.73 Million - $3.02 Million
-24,954 Reduced 3.31%
727,827 $82.7 Million
Q4 2023

Jan 24, 2024

SELL
$90.19 - $110.4 $2.57 Million - $3.14 Million
-28,442 Reduced 3.64%
752,781 $82.9 Million
Q3 2023

Oct 19, 2023

SELL
$95.53 - $114.62 $311,905 - $374,234
-3,265 Reduced 0.42%
781,223 $75.7 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $696,692 - $776,260
-6,913 Reduced 0.87%
784,488 $85.5 Million
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $124,755 - $146,844
-1,288 Reduced 0.16%
791,401 $80.1 Million
Q4 2022

Feb 06, 2023

SELL
$95.06 - $111.52 $3.11 Million - $3.65 Million
-32,687 Reduced 3.96%
792,689 $87 Million
Q3 2022

Nov 04, 2022

SELL
$96.76 - $112.03 $2.41 Million - $2.8 Million
-24,951 Reduced 2.93%
825,376 $79.9 Million
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $4.71 Million - $5.69 Million
-46,146 Reduced 5.15%
850,327 $92.4 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $6.3 Million - $7.68 Million
-55,257 Reduced 5.81%
896,473 $106 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $4.51 Million - $5.52 Million
38,998 Added 4.27%
951,730 $134 Million
Q3 2021

Nov 02, 2021

SELL
$116.66 - $129.06 $2.26 Million - $2.5 Million
-19,389 Reduced 2.08%
912,732 $108 Million
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $2.28 Million - $2.68 Million
21,524 Added 2.36%
932,121 $108 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.65 Million - $1.94 Million
-15,161 Reduced 1.64%
910,597 $109 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.57 Million - $1.71 Million
-14,946 Reduced 1.59%
925,758 $100 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $1.02 Million - $1.23 Million
-11,095 Reduced 1.17%
940,704 $102 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $1.36 Million - $1.74 Million
-17,798 Reduced 1.84%
951,799 $87 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $509,533 - $745,076
-8,111 Reduced 0.83%
969,597 $76.5 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $236,079 - $262,811
3,007 Added 0.31%
977,708 $84.9 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $1.26 Million - $1.37 Million
15,386 Added 1.6%
974,701 $81.6 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $6.9 Million - $8.04 Million
94,611 Added 10.94%
959,315 $80.7 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $132 Million - $159 Million
-1,990,423 Reduced 69.71%
864,704 $69.1 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $1.27 Million - $1.43 Million
19,308 Added 0.68%
2,855,127 $206 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $715,916 - $863,667
11,773 Added 0.42%
2,835,819 $208 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $2.94 Million - $3.24 Million
51,038 Added 1.84%
2,824,046 $172 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $1.75 Million - $1.97 Million
31,039 Added 1.13%
2,773,008 $166 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $1.23 Million - $1.32 Million
-22,977 Reduced 0.83%
2,741,969 $157 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $108,903 - $121,548
2,266 Added 0.08%
2,764,946 $148 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,762,680
2,762,680 $134 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.